Karen Smith
Director/Board Member chez EMYRIA LIMITED
Fortune : 241 278 $ au 31/03/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Martin | M | 52 | 31 ans | |
Robert Foster | M | 65 | 31 ans | |
Peter Greenleaf | M | 54 | 6 ans | |
H. Parker | F | 68 | 10 ans | |
Stephen Robertson | M | 42 | 10 ans | |
Laura Shawver | M | 66 |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
Philip Low | M | 76 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | 2 ans |
Michael Winlo | M | - | 5 ans | |
Alexander Macrae | M | 61 | 8 ans | |
Daniel Billen | M | 70 | 5 ans | |
Simon Read | M | - |
Mariana Oncology, Inc.
Mariana Oncology, Inc. Pharmaceuticals: MajorHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | - |
Aaron Rosenberg | M | - | 3 ans | |
Prathyusha Durabaibu | F | 46 | 5 ans | |
Stewart A. Low | M | - |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | - |
June Bray | F | 70 | 2 ans | |
Margaret Somerville | F | - | - | |
John Markels | M | 58 | 4 ans | |
James Meyers | M | 58 | 5 ans | |
Scott Willoughby | M | - | - | |
Lexi O’Halloran | F | - | - | |
Kimberly McCutcheon Jablonski | F | - | 21 ans | |
Louise Wilkie | F | - | 4 ans | |
Haig Aghajanian | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | 2 ans |
Karen Smith | F | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
Phillip Ramsey | M | - | - | |
Gregory Davis | M | - | 4 ans | |
Sandy Mong | M | - |
Mariana Oncology, Inc.
Mariana Oncology, Inc. Pharmaceuticals: MajorHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | - |
Brinda Balakrishnan | M | 44 | 3 ans | |
Linda Bain | F | 53 |
Mariana Oncology, Inc.
Mariana Oncology, Inc. Pharmaceuticals: MajorHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | 1 ans |
Robert Carey | M | 65 | 8 ans | |
Simon Read | M | 53 |
Mariana Oncology, Inc.
Mariana Oncology, Inc. Pharmaceuticals: MajorHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | 3 ans |
David Jaynee | M | 67 | 9 ans | |
Duncan Moore | M | 65 | 8 ans | |
Greg Hutchinson | M | - | 1 ans | |
Rita Karachun | F | 63 | 3 ans | |
Daniel Hasler | M | 66 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | - |
R. MacKay-Dunn | M | 73 | 5 ans | |
Helen Torley | M | 61 | 8 ans | |
Jon Filderman | M | - | 3 ans | |
Jeffrey Bailey | M | 62 | 1 ans | |
Jill Leversage | F | 67 | 5 ans | |
Kenneth Hillan | M | 63 | 4 ans | |
Amy Pooler | F | - | - | |
Tracie Ernenwein | F | - | - | |
Joseph Miller | M | 50 | 4 ans | |
Sue Evans | F | - | 10 ans | |
Jerome Mychalowych | M | - | 3 ans | |
Jamie Bernard | M | - | 4 ans | |
Tim Power | M | - | 18 ans | |
Lisa Wyman | F | - | 5 ans | |
Haley Chartres | M | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Robert F. Apple | M | 58 | 16 ans | |
Christopher Lowe | M | 56 | 3 ans | |
James Hindman | M | 63 | 31 ans | |
Jeffrey Edwards | M | 64 | 22 ans | |
Peter J. Graham | M | 57 | 7 ans | |
Steven R. Deitcher | M | 59 |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | - |
Joseph Zakrzewski | M | 60 | 11 ans | |
James Cornelius | M | 81 | 10 ans | |
Peter R. Dolan | M | 68 | 18 ans | |
Leonard S. Jacob | M | 75 | 15 ans | |
Caryn G. McDowell | F | 54 | 2 ans | |
David Pyott | M | 70 | 17 ans | |
John Quisel | M | 53 | 14 ans | |
Gary Loeb | M | 54 | 2 ans | |
Jacques Gonella | M | 82 | 18 ans | |
Vivid Sehgal | M | 56 | 8 ans | |
Habib Dable | M | 54 | 5 ans | |
Ambrose Bailey | M | 60 | - | |
Herb Boyer | M | 87 | 19 ans | |
Kathy Yi | F | 52 | 2 ans | |
Francois Nader | M | 67 | 7 ans | |
Ted Monohon | M | 58 | 4 ans | |
Michael Holmes | M | - | 17 ans | |
R. Ramelmeier | M | 62 | 5 ans | |
Rosemary Crane | F | 64 | 20 ans | |
John Tsai | M | 57 | 11 ans | |
Thomas McCourt | M | 66 | 5 ans | |
Laura Hamill | F | 60 | 1 ans | |
Douglas Manion | M | 64 | 11 ans | |
David Berk | M | 45 | 6 ans | |
Gerald Bruce | M | 68 | 8 ans | |
George Golumbeski | M | 67 | 7 ans | |
Richard Pops | M | 62 | 15 ans | |
Harrison Bains | M | 80 | 16 ans | |
Louis J. Freeh | M | 74 | 8 ans | |
Timothy Meeker | M | 77 | 13 ans | |
Robert Williams | M | 75 | 7 ans | |
Heather Turner | F | 51 | 1 ans | |
Louis Gerstner | M | - | - | |
Vicki Sato | M | 75 | 15 ans | |
Kemal Malik | M | 61 | - | |
Roger Jeffs | M | 62 | 2 ans | |
Jean George | F | 66 | 15 ans | |
Steven Mento | M | 72 | 14 ans | |
Maria Hilado | F | 59 | 4 ans | |
Mark W. Durand | M | 64 | 17 ans | |
David J. Helfgott | M | - | - | |
Rahul Khara | M | - | 3 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 81 | 81,82% |
Canada | 12 | 12,12% |
Australie | 6 | 6,06% |
Danemark | 1 | 1,01% |
Irlande | 0 | -.--% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Karen Smith
- Réseau Personnel